INTERNATIONAL PATENT: F. HOFFMANN-LA ROCHE AG, HOFFMANN-LA ROCHE INC., GENENTECH, INC. FILES APPLICATION FOR "COMBINATION TREATMENT OF AN ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODY AND CHEMOTHERAPY IN CTDNA HIGH RISK PATIENTS"

GENEVA, May 5 -- F. HOFFMANN-LA ROCHE AG (Grenzacherstrasse 1244070 Basel), HOFFMANN-LA ROCHE INC. (Overlook at Great Notch, 150 Clove Road8th Floor, Suite 8 - Legal DepartmentLittle Falls, New Jersey 07424), GENENTECH, INC. (1 DNA WaySouth San Francisco, California 94080) filed a patent application (PCT/EP2024/079877) for "COMBINATION TREATMENT OF AN ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODY AND CHEMOTHERAPY IN CTDNA HIGH RISK PATIENTS" on Oct 23, 2024. With publication no. WO/2025/087936, the details related to the patent application was published on May 01, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO)....